What Is Drug Diversion? Methods, Penalties, and Consequences

Drug diversion is the illegal redirection of prescription medications away from the patient or purpose they were prescribed for. The term covers a wide range of conduct: a patient selling leftover painkillers, a nurse replacing a fentanyl vial with saline, a physician writing prescriptions without a legitimate medical reason, a wholesaler shipping suspiciously large opioid orders without flagging them. The Centers for Medicare and Medicaid Services defines it as the illegal distribution or abuse of prescription drugs, or their use for purposes not intended by the prescriber.1Centers for Medicare & Medicaid Services. Drug Diversion: What Is a Prescriber’s Role in Preventing the Diversion of Prescription Drugs The CDC frames it more narrowly around clinical settings, describing it as healthcare providers obtaining or using prescription medicines illegally.2Centers for Disease Control and Prevention. Clinician Brief: Drug Diversion Both definitions describe the same core idea: a regulated drug ending up somewhere it was never supposed to go.

Diversion can happen at any point along the pharmaceutical supply chain. The FDA identifies it alongside counterfeiting, theft, and falsified imports as a primary threat to supply-chain integrity, with drugs vulnerable to siphoning at the manufacturing plant, during wholesale distribution, at the physician’s office, inside the pharmacy, and after the medication reaches a patient’s home.3Food and Drug Administration. Drug Supply Chain Integrity

How Diversion Happens

Doctor Shopping

One of the oldest methods. A person visits multiple physicians, often exaggerating or fabricating symptoms, to collect prescriptions for the same controlled substance from several prescribers, then fills them at different pharmacies to avoid any one pharmacist noticing the pattern.4National Drug Intelligence Center. Pharmaceuticals Drug Threat Assessment – Section: Doctor Shopping State Prescription Drug Monitoring Programs have made this harder, but gaps between state databases still create openings, particularly across state lines.

Prescription Fraud

Forged or altered prescriptions remain persistent. Someone might steal a prescription pad, create a counterfeit script, or modify an existing one to increase the quantity or change the drug. CMS lists prescription pad theft and forgery among the most common diversion methods.5Centers for Medicare & Medicaid Services. What Is a Prescriber’s Role in Preventing the Diversion of Prescription Drugs Electronic prescribing has reduced this somewhat, but paper prescriptions still circulate.

Theft Inside Healthcare Facilities

Pharmacy break-ins get the headlines, but the harder-to-detect theft happens inside hospitals and clinics. The CDC has documented methods including pocketing partial doses, replacing opioid vials with saline, pulling medications for patients who never needed them, creating false verbal orders, substituting controlled substances with other liquids, and pulling discarded medication from sharps containers.2Centers for Disease Control and Prevention. Clinician Brief: Drug Diversion

Illegal Online Sales and Patient-Level Sharing

Rogue internet pharmacies sell controlled substances without valid prescriptions or any meaningful medical oversight. At the other end of the chain, patients themselves sometimes sell or share pills they were legitimately prescribed. CMS treats patient diversion, illegal internet pharmacies, and illicit prescribing as distinct but overlapping categories.5Centers for Medicare & Medicaid Services. What Is a Prescriber’s Role in Preventing the Diversion of Prescription Drugs

Who Diverts Drugs

Patients can be diverters, victims, or both. Some sell or give away medications they were legitimately prescribed. Others doctor-shop to stockpile pills for personal use or resale. And some patients have their prescriptions stolen by family members or visitors with access to their medicine cabinets.

Healthcare professionals occupy a different position because of the access they have. Physicians may write prescriptions without a genuine medical basis. Nurses working with injectable opioids can skim doses or swap drugs for saline. Pharmacists and technicians handle controlled inventory daily. The CDC emphasizes that healthcare-worker diversion creates a cascade of harm: the impaired provider delivers substandard care, patients are denied medication they need, and when injectable drugs are tampered with, patients can contract infections.2Centers for Disease Control and Prevention. Clinician Brief: Drug Diversion

Manufacturers and distributors are also potential sources. Federal regulations require every DEA registrant involved in making or distributing controlled substances to maintain effective controls against theft and diversion.6eCFR. 21 CFR 1301.71 – Security Requirements Generally Distributors have a separate obligation to identify and report suspicious orders. When these safeguards fail, large quantities can flood areas far beyond what legitimate medical need would justify, and the DEA has pursued major enforcement actions against distributors who shipped unusually large opioid volumes without flagging them.7Drug Enforcement Administration. Guidance Document: Manufacturer and Distributor Established Controlled Substance Quantitative Thresholds and the Requirement to Report Suspicious Orders

Which Drugs Get Diverted Most

Prescription opioid painkillers top the list. Oxycodone (OxyContin, Percocet), hydrocodone (Vicodin, Lortab), fentanyl, morphine, and methadone are the drugs most commonly diverted in the United States, and they command high street prices.8Centers for Medicare & Medicaid Services. Drug Diversion in the Medicaid Program The rate of overdose deaths involving prescription opioids dropped roughly 12 percent between 2022 and 2023, but the cumulative toll over two decades remains severe.9Centers for Disease Control and Prevention. Understanding the Opioid Overdose Epidemic

Stimulants are the next major category. Amphetamine (Adderall) and methylphenidate (Ritalin), both Schedule II drugs prescribed primarily for ADHD, are sought on the black market for focus, appetite suppression, and euphoria at high doses. Expanded legitimate prescribing has increased the volume available for diversion.10National Drug Intelligence Center. National Prescription Drug Threat Assessment 2009 – Legitimate Distribution of CPDs

Benzodiazepines (Xanax, Klonopin, Ativan, Valium) are Schedule IV drugs prescribed for anxiety, insomnia, and seizures. They are especially dangerous when combined with opioids or alcohol, a pattern common among people using diverted supplies. CMS data linked benzodiazepines to roughly 272,000 emergency department visits.8Centers for Medicare & Medicaid Services. Drug Diversion in the Medicaid Program

Diversion is spreading beyond traditional controlled substances. Gabapentin, originally approved as a non-controlled drug for nerve pain and seizures, has become a significant concern because it amplifies opioid effects and dramatically increases overdose risk when combined. As of late 2024, eight states had reclassified gabapentin as a Schedule V controlled substance to bring it under PDMP tracking.11National Center for Biotechnology Information (NCBI). A Comprehensive Analysis of Jurisdiction-Specific Laws Related to Gabapentin Veterinary medications are another growing channel. Ketamine, xylazine, and other sedatives and painkillers prescribed for animals have increasingly appeared in the illicit supply, with pet owners and veterinary staff as the primary diverters.12National Center for Biotechnology Information (NCBI). Unsettling Trend: The Alarming Rise of Human Abuse of Veterinary Drugs and Its Consequences

The Harm to Patients Who Never Used the Drug

Diversion inside healthcare facilities causes harm that reaches beyond the diverter’s own use. When a nurse swaps a patient’s opioid for saline, that patient suffers uncontrolled pain. When a worker uses contaminated needles or vials to tamper with injectable drugs, patients can be infected. Outbreak investigations have traced more than 100 infections and nearly 30,000 potentially exposed patients to drug diversion in U.S. healthcare facilities over roughly a ten-year period. Six separate outbreaks involved tampering with fentanyl syringes or patient-controlled analgesia pumps, resulting in hepatitis C transmission to 84 patients and gram-negative bacterial infections in 34 others. In each hepatitis C outbreak, the responsible healthcare worker was personally infected and served as the transmission source.13National Center for Biotechnology Information (NCBI). Outbreaks of Infections Associated With Drug Diversion by US Health Care Personnel

Federal Criminal Penalties

Federal law treats diversion as a serious offense, and the penalties scale with both the drug’s schedule under the Controlled Substances Act and the severity of the conduct. The Act groups regulated drugs into five schedules by medical use and abuse potential; Schedule II contains the most commonly diverted prescription drugs (oxycodone, fentanyl, hydrocodone, Adderall, Ritalin), while benzodiazepines sit in Schedule IV and cough preparations with small amounts of codeine fall into Schedule V.14Drug Enforcement Administration. Drug Scheduling

Illegal Distribution and Dispensing

Illegally distributing or dispensing a controlled substance falls under 21 U.S.C. § 841. For a Schedule II substance, a first offense carries up to 20 years in prison; if someone dies or suffers serious bodily injury from the distributed substance, the minimum jumps to 20 years and the maximum reaches life, with fines up to $1 million for an individual. Schedule III offenses carry up to 10 years, rising to 15 if death or serious injury results, with fines up to $500,000. Schedule IV offenses carry up to 5 years and fines up to $250,000. Schedule V offenses carry up to 1 year. Repeat offenders face roughly double these maximums.15Office of the Law Revision Counsel. 21 USC 841 – Prohibited Acts A

Fraud, Forgery, and Doctor Shopping

Using a forged prescription, acquiring controlled substances through fraud or deception, and knowingly furnishing false information on required records are covered by 21 U.S.C. § 843. A first offense carries up to four years in prison and a fine. A repeat offense doubles the maximum to eight years.16Office of the Law Revision Counsel. 21 USC 843 – Prohibited Acts C

Regulatory Violations by Registrants

Manufacturers, distributors, and pharmacies that fail to maintain proper controls face civil penalties under 21 U.S.C. § 842. The general civil fine is up to $25,000 per violation. For opioid-specific failures, including not reporting suspicious orders or failing to maintain effective diversion controls, the fine can reach $100,000 per violation.17Office of the Law Revision Counsel. 21 USC 842 – Prohibited Acts B A knowing regulatory violation prosecuted criminally can add up to one year in prison.

Professional and Reporting Consequences

Criminal penalties are only part of the picture for healthcare professionals. State licensing boards can revoke, suspend, or restrict a provider’s license. The DEA can pull a provider’s controlled-substance registration. Both actions must be reported to the National Practitioner Data Bank within 30 days, where they become part of the provider’s permanent record and are visible to hospitals, health plans, and licensing authorities nationwide. Healthcare-related criminal convictions and Medicare or Medicaid exclusions are also reported there.18National Practitioner Data Bank (NPDB). What You Must Report to the NPDB

Facilities themselves face reporting deadlines when diversion is discovered. A DEA registrant who finds a theft or significant loss must notify the local DEA field office in writing within one business day,19eCFR. 21 CFR 1301.76 – Other Security Controls for Practitioners and submit a completed DEA Form 106 through the agency’s online portal within 45 days.20Drug Enforcement Administration. Theft/Loss Reporting Whether a loss qualifies as “significant” depends on factors listed in the regulation: the quantity relative to the business’s size, which substances went missing, whether the loss ties to particular individuals or activities, whether there is a pattern of losses, and whether the drugs are known diversion candidates based on local trends. Registrants who fail to report can face civil penalties and risk losing their DEA registration. Trading partners in the pharmaceutical supply chain have a separate 24-hour window to notify the FDA after determining a product in their possession is illegitimate, under the Drug Supply Chain Security Act.21U.S. Food and Drug Administration. Drug Supply Chain Security Act